Page last updated: 2024-08-23

etoposide and Breast Cancer, Male

etoposide has been researched along with Breast Cancer, Male in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harada, M; Hayashi, K; Kohara, H; Shinagawa, K; Tabata, M; Ueoka, H	1
Aref, IM; Cross, PW; Gertler, SZ; Grimard, LJ; Hanson, J; Huan, SD; Malik, ST; St Cyr, DA; Stewart, DJ; Tomiak, EM; Verma, S; Yau, JC	1
Jun Yang, Y	1

Trials

1 trial(s) available for etoposide and Breast Cancer, Male

Article	Year
A phase III study of high-dose intensification without hematopoietic progenitor cells support for patients with high-risk primary breast carcinoma. American journal of clinical oncology, 2000, Volume: 23, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Risk Factors; Survival Analysis	2000

Article

Year

A phase III study of high-dose intensification without hematopoietic progenitor cells support for patients with high-risk primary breast carcinoma.

American journal of clinical oncology, 2000, Volume: 23, Issue:3

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Risk Factors; Survival Analysis

2000

Other Studies

2 other study(ies) available for etoposide and Breast Cancer, Male

Article	Year
High-dose etoposide treatment for CNS involvement in a patient with primary non-Hodgkin's lymphoma of the breast. Internal medicine (Tokyo, Japan), 1997, Volume: 36, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms, Male; Cerebrospinal Fluid; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, Large-Cell, Immunoblastic; Magnetic Resonance Imaging; Male; Middle Aged; Prednisone; Vincristine	1997
Gynecomastia with marked cellular atypia associated with chemotherapy. Archives of pathology & laboratory medicine, 2002, Volume: 126, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms, Male; Carcinoma, Intraductal, Noninfiltrating; Cytarabine; Daunorubicin; Diagnostic Errors; Etoposide; Gynecomastia; Humans; Leukemia, Myelomonocytic, Acute; Male	2002

Article

Year

High-dose etoposide treatment for CNS involvement in a patient with primary non-Hodgkin's lymphoma of the breast.

Internal medicine (Tokyo, Japan), 1997, Volume: 36, Issue:10

Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms, Male; Cerebrospinal Fluid; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, Large-Cell, Immunoblastic; Magnetic Resonance Imaging; Male; Middle Aged; Prednisone; Vincristine

1997

Gynecomastia with marked cellular atypia associated with chemotherapy.

Archives of pathology & laboratory medicine, 2002, Volume: 126, Issue:5

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms, Male; Carcinoma, Intraductal, Noninfiltrating; Cytarabine; Daunorubicin; Diagnostic Errors; Etoposide; Gynecomastia; Humans; Leukemia, Myelomonocytic, Acute; Male

2002